Why the study?
Do dialysable fibrinogen degradation products inhibit platelet aggregation?
Do dialysable fibrinogen degradation products inhibit platelet aggregation?
Answers are grounded in this paper and cite their sources.
Identifies a specific low molecular weight fragment of fibrinogen degradation products capable of inhibiting platelet aggregation.
Summary During prolonged proteolysis of fibrinogen by plasmin dialysable, low molecular fragments accumulate which inhibit platelet aggregation induced by thrombin, ADP, adrenaline and noradrenaline. These fragments isolated by dialysis were separated on sephadex G-25 column. The active component has probably a molecular weight lower than 5,000 and does not contain aromatic amino acids.
No takes yet. Share an insight, caveat, or question.
Stachurska et al. (1970) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: